Analysis
The $35.6 billion aggregate number describing defense tech's year -- up roughly 40% against 2025's full-year pace -- is easy to cite and hard to actually picture. The named rounds underneath it are more useful, because they show where the money is concentrating and why:
- Anduril Industries -- $5B Series H at $61B valuation (led by Andreessen Horowitz and Thrive Capital): the category's flagship, doubling its valuation from $30.5B less than a year earlier and taking total funding to $11.4B, per Crunchbase News. Founded 2017 by Palmer Luckey and a team from Oculus. Builds autonomous defense systems -- drones, counter-drone systems, the Lattice software platform. Competitors: Palantir, Shield AI, traditional primes like Lockheed and RTX.
- Castelion -- $1B Series C at $13B valuation (co-led by Andreessen Horowitz, Carlyle and JPMorgan Chase): founded 2022 by former SpaceX engineers, building hypersonic weapon systems at lower cost and faster production speed than traditional primes. Has secured more than $500M in U.S. military contracts, per TechCrunch.
- True Anomaly -- $600M raised (led by Eclipse and Riot Ventures): Centennial, Colorado-based space-security infrastructure company, part of the same wave of capital pouring into orbital and counter-space defense capability.
What the comps actually tell you
Every one of these three rounds is priced by growth-stage and crossover capital -- Andreessen Horowitz appears on two of the three, Carlyle and JPMorgan on the third -- not by traditional early-stage defense-tech specialists. That's the real story behind the 40% year-over-year growth figure: the category has graduated from a niche that only defense-focused funds would touch into one where generalist growth capital is competing directly for allocation, the same dynamic that happened to fintech in the late 2010s and to AI infrastructure over the past two years. Pulse has tracked defense tech's funding boom building through the year.
The valuations also compress an unusually wide range of company maturity into comparable multiples. Anduril at $61 billion is a nine-year-old company with real, recurring military contract revenue and a demonstrated production track record. Castelion at $13 billion is four years old and still scaling toward the kind of contract volume Anduril already has. True Anomaly's $600 million round doesn't disclose a valuation at all in public reporting, which is itself a signal that late-stage growth investors are willing to write large checks into space-security infrastructure even without full valuation transparency -- a pattern more common in genuinely scarce, high-conviction categories than in crowded ones.
Counterweight
Defense-tech valuations carry a structural risk that doesn't show up in the growth numbers: revenue durability depends on multi-year government procurement cycles that can shift hard with a change in administration priorities, a budget continuing resolution, or a single high-profile program cancellation. Anduril's own valuation trajectory -- doubling in under a year -- is the kind of move that historically precedes a correction if contract wins don't keep pace with the marked-up price. None of the three companies above has been tested through a genuine defense-budget contraction yet, because there hasn't been one during this funding cycle.
What's worth watching next is whether the growth-stage capital now dominant in these rounds sticks around through a slower year, or whether it rotates out the same way generalist crossover capital did in fintech once growth decelerated -- defense-tech-specialist funds are the ones that will still be writing checks either way.
